Positron Corporation (POSC)
OID · Healthcare · Medical Devices
Closing price as of 2026-07-29 · Source: TEK2day Finance
Key Metrics
About Positron Corporation
Positron Corporation, a medical technology company, co-develops, manufactures, and sells positron emission tomography and PET-computed tomography imaging systems in the United States. The company offers Attrius PET and NeuSight PET-CT 64-slice used in non-invasive diagnosis and evaluation of coronary artery disease and supports various molecular imaging applications, including cardiology, oncology, and neurology. It also provides clinical and technical support services, such as physician interpretation training, nurse and technologist training, billing and prior-authorization assistance, physician over-read services, 24/7 clinical and technical support, priority response with after-hours service availability, equipment uptime guarantees and software upgrades, and remote system diagnostics and maintenance capabilities. The company sells its products through internal sales and marketing team. It serves healthcare providers, imaging centers, hospitals, and cardiology practices. The company was incorporated in 1983 and is headquartered in North Tonawanda, New York.
Quarterly Financials
| Metric | 2025-03-31 | 2026-03-31 |
|---|---|---|
| Revenue | 119K | 111K |
| Gross Profit | -258K | -527K |
| Operating Income | -1.5M | -1.4M |
| Net Income | -1.5M | -1.4M |
| Diluted EPS | $-0.05 | $-0.04 |
Annual Financials
| Metric | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Revenue | 588K | 461K |
| Gross Profit | -342K | -2.1M |
| Operating Income | -2.2M | -10.5M |
| Net Income | -2.4M | -10.6M |
| Diluted EPS | $-0.09 | $-0.34 |